Internal Medicine, Infectious Disease · Las Vegas, NV
NPI
1972538247
Since 2006
Specialty
Internal Medicine, Infectious Disease
Code 207RI0200X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
653 N Town Center Dr Ste 510
Las Vegas, NV, 89144
Phone (702) 467-7119
Groups this clinician bills Medicare through
Medicare paid, 2024
$196K
2,702 services
Medicare patients, 2024
549
Average age 74
Drug cost, 2024
$438K
644 prescriptions
Company payments, 2025
$258
From 3 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Amir Z Qureshi was code 99232 (hospital e&m - subsequent), 1,899 times for 465 patients. In total Amir Z Qureshi billed 2,702 services in 10 codes, and Medicare paid $196K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-07-10.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99232 Hospital E&M - Subsequent | Facility | 1,899 | 465 | $62.36 | $118K |
| 99233 Hospital E&M - Subsequent | Facility | 335 | 139 | $93.90 | $31K |
| 99222 Hospital E&M - Initial | Facility | 197 | 184 | $103.35 | $20K |
| 99213 Office E&M - Established | Office | 155 | 62 | $69.29 | $11K |
| 99223 Hospital E&M - Initial | Facility | 92 | 88 | $136.11 | $13K |
By year: 2022 $226K for 3,232 services; 2023 $223K for 3,031 services; 2024 $196K for 2,702 services.
Medicare prescription drug claims, 2024
In 2024, the drug Amir Z Qureshi prescribed most often to Medicare patients was Daptomycin, with 146 prescriptions and refills. In total Amir Z Qureshi wrote 644 Medicare prescriptions that cost $438K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Daptomycin Generic | 146 | 146 | 42 | $218K |
| Ceftriaxone Ceftriaxone Sodium | 131 | 131 | 34 | $5,340 |
| Ertapenem Ertapenem Sodium | 58 | 58 | 26 | $27K |
| Meropenem Generic | 46 | 46 | 15 | $7,551 |
| Cefepime Hcl Generic | 41 | 41 | 16 | $6,534 |
| Cefazolin Sodium Generic | 29 | 29 | Under 11 | $1,103 |
| Doxycycline Hyclate Generic | 27 | 33 | Under 11 | $944 |
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 22 | 22 | Under 11 | $93K |
| Ethambutol Hcl Generic | 22 | 22 | Under 11 | $824 |
| Fluconazole Generic | 16 | 16 | Under 11 | $171 |
| Vancomycin Hcl Generic | 15 | 15 | Under 11 | $964 |
| Rifabutin Generic | 14 | 14 | Under 11 | $4,891 |
| Cephalexin Generic | 12 | 13 | Under 11 | $156 |
| Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav | 11 | 11 | Under 11 | $289 |
Brand drugs: 41 claims; generic drugs: 603 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Amir Z Qureshi $258 ($258 in general payments such as food, travel and fees) from 3 companies. The largest payer was Abbvie Inc. with $204.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.